A West Coast biotechnology firm says it will pour $2.5 million into research at Scripps Florida over the next 26 months to develop new anti-cancer and other drugs.

In return, Seattle-based NeoRx will have exclusive global rights to commercialize the compounds developed through the partnership.
[CML]
A group of CMLHope.Com
Subscribe: [EMAIL PROTECTED]
Web Site: http://groups.cmlhope.com 

Reply via email to